$1.73
▼ $-0.01
(-0.57%)
Vol 1.7M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$447.6M
ROE
-84.2%
D/E
0.00
Beta
1.91
52W
$1–$7
Wall Street Consensus
13 analysts · Apr 20267
Strong Buy
4
Buy
1
Hold
1
Sell
0
Strong Sell
84.6%
Buy Rating
Price Chart
Similar Stocks
KLRS
Kalaris Therapeutics Inc
$141.3M
AGEN
Agenus Inc
$106.8M
EQ
Equillium Inc
$94.4M
HUMA
Humacyte Inc
$185.4M
IMDX
Insight Molecular Diagnostics Inc
$215.0M
GNLX
Genelux Corp
$165.9M
SGMO
Sangamo Therapeutics Inc
$141.3M
BMEA
Biomea Fusion Inc
$87.7M
KPTI
Karyopharm Therapeutics Inc
$125.5M
CRDF
Cardiff Oncology Inc
$189.3M
Earnings
Beat rate: 75.0%
Next Report
May 06, 2026
EPS Estimate: $-0.32
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.32 | — | — |
| Dec 2025 | $-0.38 | $-0.27 | +$0.11 |
| Sep 2025 | $-0.58 | $-0.52 | +$0.06 |
| Jun 2025 | $-0.84 | $-0.70 | +$0.14 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -92.5% | -92.5% | -92.5% | -92.5% | -84.2% | -84.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 4.74 | 4.74 | 4.74 | 4.74 | 13.15 | 13.15 |
Key Ratios
ROA (TTM)
-65.6%
P/B
1.0
EPS (TTM)
$-2.84
CF/Share
$-3.07
52W High
$6.72
52W Low
$0.88
$0.88
52-Week Range
$6.72
How does PEPG compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PEPG valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.0
▼
58%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PEPG profitability vs Biotechnology peers
ROE
-84.2%
▼
25%
below
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-65.6%
▼
40%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
PEPG financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
13.2
▲
196%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.9
▲
96%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PEPG fundamentals radar
PEPG
Peer median
Industry
PEPG profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PEPG vs peers: key metrics
Latest News
No related news yet